John Vanecko is an accomplished professional in the pharmaceutical industry, currently serving as Director of CMC Drug Substance at Xenon Pharmaceuticals Inc., responsible for leading early phase development programs and vendor negotiations. Previously, John co-founded ChemStrat CMC Solutions, providing CMC support and strategic advice for various projects. John's extensive experience spans roles at Pfizer, Array BioPharma, Gilead Sciences, and Amgen, focusing on external manufacturing and CMC activities throughout multiple phases of drug development. An MBA graduate from USC Marshall School of Business, John has a strong foundation in finance and operations, complemented by advanced degrees in organic chemistry, including a PhD from the University of Utah.
This person is not in any offices